Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Arecor, GSK In Vax Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Arecor, GSK In Vax Pact

Arecor and GlaxoSmithKline have entered into a license agreement to develop advanced formulations of vaccines combining Arecor’s formulation technologies with GSK’s proprietary vaccines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Arecor and GlaxoSmithKline have entered into a license agreement to develop advanced formulations of vaccines combining Arecor’s formulation technologies with GSK’s proprietary vaccines. GSK and Arecor will work to develop new approaches that could offer significant improvements to the administration of several vaccines in development. Arecor will receive payments on relevant development milestones and royalties on sales.

Tom Saylor, chief executive officer of Arecor, said, “Arecor is pleased to work closely with one of the global leaders in vaccine products and technology. The relationship with GSK offers Arecor the potential to apply its broad-ranging expertise in biomolecule stabilization to specific projects with GSK.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters